SlideShare a Scribd company logo
1 of 10
Training for rotavirus vaccine introduction
Module 3
Rotavirus vaccine eligibility
Last updated March 2022
Rotavirus vaccine eligibility, Module 3 | March 2022
2 |
Learning objectives
 At the end of the module, the participant will be
able to:
– Describe the recommended immunization schedule for
rotavirus vaccine
– Describe when an infant is eligible for rotavirus
vaccine and when he/she is not eligible
– Describe ways to determine an infant’s eligibility for
rotavirus vaccine when a written record is unavailable
– Describe the absolute contraindications for vaccination
 Duration
– 60’
Rotavirus vaccine eligibility, Module 3 | March 2022
3 |
Key issues
What is the schedule for rotavirus
vaccine?
1
What to do when the exact date of
birth (DOB) or immunization card is
missing?
2
What are the contraindications for
vaccination?
3
Rotavirus vaccine eligibility, Module 3 | March 2022
4 |
 Rotavac 5D® vaccine is given in a 3-dose schedule at 6, 10 and 14
weeks of age
 Rotavac 5D® vaccine can be given at same time as other vaccines
in the schedule, such as DTP-HepB-Hib (i.e. Penta1, Penta2 and
Penta3)
 Maintain an interval of 4 weeks between doses, starting 6 weeks
What is the rotavirus vaccine schedule?
6
Birth 10 14
32 weeks
Rota 1 Rota 2 Rota 3
Rotavirus vaccine eligibility, Module 3 | March 2022
5 |
Late vaccination
• If a child misses a rotavirus dose or series for any reason, late
vaccination for that child can take place at any time before 24
months of age
• The interrupted vaccine schedule should be resumed without
repeating the previous dose
• If the child is older than 24 months of age, the rotavirus vaccine
should not be given
Rotavirus vaccine eligibility, Module 3 | March 2022
6 |
Product interchangeability
• WHO recommends that the rotavirus vaccination series for each
child be completed with the same product whenever feasible
• If the product for the prior dose is unavailable or unknown,
complete the series with any available licensed product.
Restarting the series is not recommended.
• If any dose in the child’s vaccine series is with a rotavirus vaccine
product that has a 3-dose schedule, e.g. Rotateq®, Rotavac®,
Rotavac 5D®, or Rotasiil®, a total of 3 doses should be
administered for a complete vaccination series
Rotavirus vaccine eligibility, Module 3 | March 2022
7 |
An infant’s immunization
card shows that he/she is
now 17 weeks old and has
only received BCG and OPV
1 vaccines.
What should you do?
What should you do in this scenario?
Rotavirus vaccine eligibility, Module 3 | March 2022
8 |
Absolute contraindications
 Hypersensitivity after previous administration of
rotavirus vaccines or to any of the components
of the vaccine
 Previous history of intussusception
 Acute infection or febrile illness may a reason
to postpone administration of Rotavac 5D®
Mild illness such as an upper respiratory tract infection
or mild diarrhoea is not a contraindication
Rotavirus vaccine eligibility, Module 3 | March 2022
9 |
Key messages
 On-time vaccination is very important for rotavirus vaccine
 First dose of Rotavac 5D® should be given at 6 weeks of age
 Second and third dose should be given at 10 and 14 weeks of age,
respectively – minimum interval of 4 weeks should be maintained between
doses
 If infants have missed their rotavirus vaccines, they can receive the vaccine
up to 24 months of age
 Rotavirus vaccine can be given simultaneously with other vaccines like
pentavalent vaccine, PCV or OPV
 Mild illness such as an upper respiratory tract infection or mild diarrhoea is
not a contraindication
Rotavirus vaccine eligibility, Module 3 | March 2022
10 |
End of module
Thank you for your
attention!

More Related Content

Similar to Rotavirus vaccine eligibility.pptx

Adult schedule-immunization
Adult schedule-immunizationAdult schedule-immunization
Adult schedule-immunization
mhelrhaine
 
CHỦNG NGỪA VÀ THAI KỲ ACOG
CHỦNG NGỪA VÀ THAI KỲ ACOGCHỦNG NGỪA VÀ THAI KỲ ACOG
CHỦNG NGỪA VÀ THAI KỲ ACOG
SoM
 

Similar to Rotavirus vaccine eligibility.pptx (20)

Adult schedule
Adult scheduleAdult schedule
Adult schedule
 
Immunisation guidlines 2013( IAP)
Immunisation guidlines 2013( IAP)Immunisation guidlines 2013( IAP)
Immunisation guidlines 2013( IAP)
 
National Immunization Schedule
National Immunization ScheduleNational Immunization Schedule
National Immunization Schedule
 
Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017Chicken pox vaccine presentation jalandhar july 2017
Chicken pox vaccine presentation jalandhar july 2017
 
Indian academy of pediatrics (iap) recommended immunization
Indian academy of pediatrics (iap) recommended immunizationIndian academy of pediatrics (iap) recommended immunization
Indian academy of pediatrics (iap) recommended immunization
 
2023-immunization-schedule-508 (1).pdf
2023-immunization-schedule-508 (1).pdf2023-immunization-schedule-508 (1).pdf
2023-immunization-schedule-508 (1).pdf
 
Vaccine hesitancy
Vaccine hesitancyVaccine hesitancy
Vaccine hesitancy
 
DNB pediatrics OSCE-Immunization
DNB pediatrics OSCE-ImmunizationDNB pediatrics OSCE-Immunization
DNB pediatrics OSCE-Immunization
 
Adult schedule-11x17
Adult schedule-11x17Adult schedule-11x17
Adult schedule-11x17
 
Adult schedule-contraindications
Adult schedule-contraindicationsAdult schedule-contraindications
Adult schedule-contraindications
 
Vaccination of the immunocompromised host
Vaccination of the immunocompromised hostVaccination of the immunocompromised host
Vaccination of the immunocompromised host
 
adult-combined-schedule.pdf
adult-combined-schedule.pdfadult-combined-schedule.pdf
adult-combined-schedule.pdf
 
VACCINES.pdf
VACCINES.pdfVACCINES.pdf
VACCINES.pdf
 
Adult schedule-immunization
Adult schedule-immunizationAdult schedule-immunization
Adult schedule-immunization
 
Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...Vaccination of pregnant women and health care workers - Slideset by Professor...
Vaccination of pregnant women and health care workers - Slideset by Professor...
 
Vaccines updates1
Vaccines updates1Vaccines updates1
Vaccines updates1
 
LAIV in India - Should we use it? Sep 2014
LAIV in India - Should we use it? Sep 2014LAIV in India - Should we use it? Sep 2014
LAIV in India - Should we use it? Sep 2014
 
CHỦNG NGỪA VÀ THAI KỲ ACOG
CHỦNG NGỪA VÀ THAI KỲ ACOGCHỦNG NGỪA VÀ THAI KỲ ACOG
CHỦNG NGỪA VÀ THAI KỲ ACOG
 
SCHOOL BASED IMMUNIZATION-AUGUST.ppt
SCHOOL BASED IMMUNIZATION-AUGUST.pptSCHOOL BASED IMMUNIZATION-AUGUST.ppt
SCHOOL BASED IMMUNIZATION-AUGUST.ppt
 
New covid 19 vaccines and trials
New covid 19 vaccines and trialsNew covid 19 vaccines and trials
New covid 19 vaccines and trials
 

Recently uploaded

Recently uploaded (20)

Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 

Rotavirus vaccine eligibility.pptx

  • 1. Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility Last updated March 2022
  • 2. Rotavirus vaccine eligibility, Module 3 | March 2022 2 | Learning objectives  At the end of the module, the participant will be able to: – Describe the recommended immunization schedule for rotavirus vaccine – Describe when an infant is eligible for rotavirus vaccine and when he/she is not eligible – Describe ways to determine an infant’s eligibility for rotavirus vaccine when a written record is unavailable – Describe the absolute contraindications for vaccination  Duration – 60’
  • 3. Rotavirus vaccine eligibility, Module 3 | March 2022 3 | Key issues What is the schedule for rotavirus vaccine? 1 What to do when the exact date of birth (DOB) or immunization card is missing? 2 What are the contraindications for vaccination? 3
  • 4. Rotavirus vaccine eligibility, Module 3 | March 2022 4 |  Rotavac 5D® vaccine is given in a 3-dose schedule at 6, 10 and 14 weeks of age  Rotavac 5D® vaccine can be given at same time as other vaccines in the schedule, such as DTP-HepB-Hib (i.e. Penta1, Penta2 and Penta3)  Maintain an interval of 4 weeks between doses, starting 6 weeks What is the rotavirus vaccine schedule? 6 Birth 10 14 32 weeks Rota 1 Rota 2 Rota 3
  • 5. Rotavirus vaccine eligibility, Module 3 | March 2022 5 | Late vaccination • If a child misses a rotavirus dose or series for any reason, late vaccination for that child can take place at any time before 24 months of age • The interrupted vaccine schedule should be resumed without repeating the previous dose • If the child is older than 24 months of age, the rotavirus vaccine should not be given
  • 6. Rotavirus vaccine eligibility, Module 3 | March 2022 6 | Product interchangeability • WHO recommends that the rotavirus vaccination series for each child be completed with the same product whenever feasible • If the product for the prior dose is unavailable or unknown, complete the series with any available licensed product. Restarting the series is not recommended. • If any dose in the child’s vaccine series is with a rotavirus vaccine product that has a 3-dose schedule, e.g. Rotateq®, Rotavac®, Rotavac 5D®, or Rotasiil®, a total of 3 doses should be administered for a complete vaccination series
  • 7. Rotavirus vaccine eligibility, Module 3 | March 2022 7 | An infant’s immunization card shows that he/she is now 17 weeks old and has only received BCG and OPV 1 vaccines. What should you do? What should you do in this scenario?
  • 8. Rotavirus vaccine eligibility, Module 3 | March 2022 8 | Absolute contraindications  Hypersensitivity after previous administration of rotavirus vaccines or to any of the components of the vaccine  Previous history of intussusception  Acute infection or febrile illness may a reason to postpone administration of Rotavac 5D® Mild illness such as an upper respiratory tract infection or mild diarrhoea is not a contraindication
  • 9. Rotavirus vaccine eligibility, Module 3 | March 2022 9 | Key messages  On-time vaccination is very important for rotavirus vaccine  First dose of Rotavac 5D® should be given at 6 weeks of age  Second and third dose should be given at 10 and 14 weeks of age, respectively – minimum interval of 4 weeks should be maintained between doses  If infants have missed their rotavirus vaccines, they can receive the vaccine up to 24 months of age  Rotavirus vaccine can be given simultaneously with other vaccines like pentavalent vaccine, PCV or OPV  Mild illness such as an upper respiratory tract infection or mild diarrhoea is not a contraindication
  • 10. Rotavirus vaccine eligibility, Module 3 | March 2022 10 | End of module Thank you for your attention!

Editor's Notes

  1. To the facilitator: Explain the key issues raised in this module to the participants. Caretakers bring their infants for immunization but before vaccinating the infant you have to be sure that he or she is eligible for rotavirus vaccine. This module will teach you to ask the right questions to determine the eligibility of an infant for rotavirus vaccine: What is the rotavirus vaccine schedule? What to do when the exact date of birth (DOB) is missing ? What to do when the immunization card is missing? What are the contraindications for vaccination?
  2. To the facilitator: Describe the vaccination schedule to the participants. Rotavac 5D® vaccine is given in a 3-dose schedule at 6 (for the 1st dose) and 10 and 14 weeks of age (for the 2nd and 3rd dose), preferably. Rotavac 5D® vaccine doses can be given at the same time as first and second dose of DTP-HepB-Hib (i.e. Penta1 and Penta2). Note that there should be an interval of at least 4 weeks between the doses.
  3. To the facilitator: Read: Banyak kasus di usia infant di bawah 2 tahun By recommending that the age restriction be removed, it was hoped that it would be possible to help protect vulnerable children in settings where DTP doses are given late. However, because of the typical age distribution of rotavirus infections, rotavirus vaccination of children > 24 months of age was not recommended.
  4. To the facilitator: Read:
  5. To the facilitator: Read the situation and question to participants. Response: The infant can still receive rotavirus vaccine. Give the first dose of rotavirus, pentavalent vaccine and other vaccines according to national schedule Administer a second dose of OPV if more than 4 weeks have passed since the first dose of OPV Make an appointment for the next doses according to the schedule Explain to the caretaker the importance of coming for vaccination on time and completing the immunization schedule Make sure to use immunization registers and community volunteers to ensure that the infant completes the immunization schedule
  6. To the facilitator: Explain to the participants the absolute contraindications. Infants suffering from the following should not be vaccinated with Rotavac 5D® vaccine. Hypersensitivity after previous administration of rotavirus vaccines: Do not give second dose of rotavirus vaccine if the infant showed hypersensitivity to first dose Known hypersensitivity to any of the components in the vaccine. Previous history of intussusception: Do not give rotavirus vaccines if the caretaker informs you that the infant has had an episode of intussusception The administration of Rotavac 5D® may be postponed in subjects suffering from acute infection or febrile illness If infant has mild illness, mild fever or mild diarrhoea, vaccinate as usual Note that mild illness such as an upper respiratory tract infection is not a contraindication.
  7. To the facilitator: Explain to the participants that these messages are the main information to keep in mind.
  8. To the facilitator: This is the end of the module. You have been introduced to “Rotavirus vaccine eligibility” module. The following module is titled “Rotavirus vaccine administration”. Thank you for your attention!